AND [TRUSTEE], TrusteeIndenture • September 1st, 2017 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 20 , among PROTAGONIST THERAPEUTICS, INC., a Delaware corporation (the “Company”), and[TRUSTEE], as trustee (the “Trustee”):
Protagonist Therapeutics, Inc. Shares of Common Stock (par value $0.00001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • September 1st, 2017 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
